Sign In
Hetero's Movfor phase-III trails show positive results
Glenmark to sell nasal spray to treat adult Covid-19 patients
Make investments more attractive in pharma sector: Pre-Budget survey
Biocon Q3FY22 revenue at Rs 2,223 crore, up by 18%
Dolo pill breaks sales record in pandemic as manufacturer makes a fortune
Glenmark Pharma inks licensing agreement to commercialize its innovative nasal spray Ryaltris
Hyderabad based Biophore to manufacture key ingredients of Pfizer's Covid drug
Govt must raise healthcare spends
Glenmark Pharma gets USFDA nod for nasal spray, Ryaltris
UPI-like digital healthcare interface to go live this week
ICMR bars Molnupiravir in Covid-19 clinical protocol
Alembic Pharma gets tentative USFDA approval for generic Vortioxetine tablets
